Trial of Enlicitide and Rosuvastatin in Healthy Adults
Treatments studied
This trial tests how a new drug called Enlicitide (MK-0616) interacts with a common cholesterol-lowering drug, Rosuvastatin. It is for healthy adults to check safety and how the drugs work together.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in generally good health with no serious medical conditions.
- You have not used any nicotine or tobacco products (like cigarettes or vapes) for at least 3 months.
- You have not taken any prescription drugs, over-the-counter medicines, herbal remedies, or vitamin supplements in the past 2 weeks.
- If you are a woman, you are not able to become pregnant.
- You are able to avoid taking any medications or supplements during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a new investigational drug, MK-4646, affects the levels of a common cholesterol medicine called rosuvastatin in healthy people. It helps researchers understand if the two drugs can be taken together safely.
This trial tests a new medication (called enlicitide) in healthy volunteers to see how well it is absorbed by the body. The study aims to find the best formulation for future use. If you are generally healthy and meet the criteria, you may be eligible to participate.
This trial tests a new medicine called MK-1406 in healthy volunteers to make sure it's safe before it can be studied in patients. If you're generally healthy, you could help advance medical research.
This is an early-phase study testing a new drug called MK-1403 in healthy people. It helps doctors learn how the drug works in the body and if it is safe.
This trial tests two experimental drugs designed to lower lipoprotein(a)—a type of cholesterol particle linked to heart disease—in people whose levels remain high despite taking statins (cholesterol-lowering medications). The goal is to see if these drugs can safely reduce this risk factor.
This trial tests a new drug called HS-10510 in healthy people to see if it is safe and how the body handles it. It is for healthy adults who meet specific weight and cholesterol levels.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.